Mark D. Smith - 05 Aug 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Aug 2026, 17:46:06 UTC
Prior SEC filing
26 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/Paz Dizon, as attorney in fact For: Mark D. Smith

Key filing fact

Mark D. Smith filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 07 Aug 2026.

Key facts

  • This page summarizes Mark D. Smith's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Aug 2026, 17:46.

Change

  • Previous filing in this sequence was filed on 26 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001756253 Primary reporting owner

Smith Mark Douglas

Relationship
Director
Address
5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature
By: /s/Paz Dizon, as attorney in fact For: Mark D. Smith
Signature date
07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Award

Transaction value
Shares
+1,605
Change %
+17%
Price
$0.000000*
Shares after
11,285
Date
05 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .